Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine Tumors

BACKGROUND: The advantages of nanomedicines include preferential delivery of the payload directly to tumor tissues. CYT-21625 is the novel, first-in-class gold nanomedicine designed to target tumor vasculature and cancer cells by specifically delivering recombinant human tumor necrosis factor alpha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Natl Cancer Inst
Main Authors: Nilubol, Naris, Yuan, ZiQiang, Paciotti, Giulio F, Tamarkin, Lawrence, Sanchez, Carmen, Gaskins, Kelli, Freedman, Esther M, Cao, Shugeng, Zhao, Jielu, Kingston, David G I, Libutti, Steven K, Kebebew, Electron
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6136933/
https://ncbi.nlm.nih.gov/pubmed/29481652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djy003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados